United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Merz Therapeutics acquires INBRIJA and FAMPYRA from Acorda Therapeutics to bolster neurological portfolio In a strategic move enhancing its presence in the neurology sector, Merz Therapeutics has successfully completed the acquisition… byPallavi MadhirajuJuly 12, 2024